232 related articles for article (PubMed ID: 33757425)
1. SAveRUNNER: an R-based tool for drug repurposing.
Fiscon G; Paci P
BMC Bioinformatics; 2021 Mar; 22(1):150. PubMed ID: 33757425
[TBL] [Abstract][Full Text] [Related]
2. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
Fiscon G; Conte F; Farina L; Paci P
PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
[TBL] [Abstract][Full Text] [Related]
3. Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis.
Adhami M; Sadeghi B; Rezapour A; Haghdoost AA; MotieGhader H
BMC Biotechnol; 2021 Mar; 21(1):22. PubMed ID: 33711981
[TBL] [Abstract][Full Text] [Related]
4. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.
Zhou Y; Hou Y; Shen J; Huang Y; Martin W; Cheng F
Cell Discov; 2020; 6():14. PubMed ID: 32194980
[TBL] [Abstract][Full Text] [Related]
5. The Anatomy of the SARS-CoV-2 Biomedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation.
Gates LE; Hamed AA
J Med Internet Res; 2020 Aug; 22(8):e21169. PubMed ID: 32735546
[TBL] [Abstract][Full Text] [Related]
6. Weighted hypergraph learning and adaptive inductive matrix completion for SARS-CoV-2 drug repositioning.
Ma Y; Zhong J; Zhu N
Methods; 2023 Nov; 219():102-110. PubMed ID: 37804962
[TBL] [Abstract][Full Text] [Related]
7. Drug repurposing approach to fight COVID-19.
Singh TU; Parida S; Lingaraju MC; Kesavan M; Kumar D; Singh RK
Pharmacol Rep; 2020 Dec; 72(6):1479-1508. PubMed ID: 32889701
[TBL] [Abstract][Full Text] [Related]
8. MCCS: a novel recognition pattern-based method for fast track discovery of anti-SARS-CoV-2 drugs.
Feng Z; Chen M; Xue Y; Liang T; Chen H; Zhou Y; Nolin TD; Smith RB; Xie XQ
Brief Bioinform; 2021 Mar; 22(2):946-962. PubMed ID: 33078827
[TBL] [Abstract][Full Text] [Related]
9. Repurposing anticancer drugs for the management of COVID-19.
El Bairi K; Trapani D; Petrillo A; Le Page C; Zbakh H; Daniele B; Belbaraka R; Curigliano G; Afqir S
Eur J Cancer; 2020 Dec; 141():40-61. PubMed ID: 33125946
[TBL] [Abstract][Full Text] [Related]
10. Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections.
Dos Santos Nascimento IJ; de Aquino TM; da Silva-Júnior EF
Curr Med Chem; 2021; 28(15):2887-2942. PubMed ID: 32787752
[TBL] [Abstract][Full Text] [Related]
11. Drug repurposing approach to combating coronavirus: Potential drugs and drug targets.
Xu J; Xue Y; Zhou R; Shi PY; Li H; Zhou J
Med Res Rev; 2021 May; 41(3):1375-1426. PubMed ID: 33277927
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential pan-coronavirus therapies using a computational drug repurposing platform.
Hwang W; Han N
Methods; 2022 Jul; 203():214-225. PubMed ID: 34767922
[TBL] [Abstract][Full Text] [Related]
13. Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action.
Yousefi H; Mashouri L; Okpechi SC; Alahari N; Alahari SK
Biochem Pharmacol; 2021 Jan; 183():114296. PubMed ID: 33191206
[TBL] [Abstract][Full Text] [Related]
14. Perspectives for repurposing drugs for the coronavirus disease 2019.
Cherian SS; Agrawal M; Basu A; Abraham P; Gangakhedkar RR; Bhargava B
Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):160-171. PubMed ID: 32317408
[TBL] [Abstract][Full Text] [Related]
15. Predicting Potential SARS-COV-2 Drugs-In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking.
Karki N; Verma N; Trozzi F; Tao P; Kraka E; Zoltowski B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557253
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19.
Vicenti I; Zazzi M; Saladini F
Expert Opin Ther Pat; 2021 Apr; 31(4):325-337. PubMed ID: 33475441
[No Abstract] [Full Text] [Related]
17. Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century.
Sanghai N; Shafiq K; Tranmer GK
Mini Rev Med Chem; 2021; 21(1):3-9. PubMed ID: 32838716
[TBL] [Abstract][Full Text] [Related]
18. Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs.
More SA; Patil AS; Sakle NS; Mokale SN
Virology; 2021 Mar; 555():10-18. PubMed ID: 33421743
[TBL] [Abstract][Full Text] [Related]
19. Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.
Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y
Arch Med Res; 2021 Jan; 52(1):38-47. PubMed ID: 32962867
[TBL] [Abstract][Full Text] [Related]
20. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]